Belgium Wound Care Management Medical Equipment Industry Report

Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies

Product Code GMD04578
Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 217
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Belgium Wound Care Management Medical Equipment Industry Report

Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies

This report is an essential source for in-depth information and data relating to Belgium wound care management medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in Belgium

Scope

  • The report provides sector information broken down into detailed categories and segments in country.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the industry at a global level, with break downs for the country
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 Table Of Contents
    • 1.1 List Of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Wound Care Management
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
      • 3.2.1 Healthcare Personnel Data
      • 3.2.2 Healthcare Facilities Data
    • 3.3 Healthcare Policy
  • 4 Wound Care Management in Belgium
    • 4.1 Wound Care Management Overall Revenues (2000-2012)
    • 4.2 Wound Care Management Overall Volume (2000-2012)
    • 4.3 Wound Care Management Overall Company Shares (2005-2006)
  • 5 Wound Closure Devices in Belgium
    • 5.1 Wound Closure Devices Overall Revenues (2000-2012)
      • 5.1.1 Skin Closure Devices Overall Revenues (2000-2012)
      • 5.1.2 Hemostats Overall Revenues (2000-2012)
      • 5.1.3 Tissue Sealants Overall Revenues (2000-2012)
    • 5.2 Wound Closure Devices Overall Volume (2000-2012)
      • 5.2.1 Skin Closure Devices Overall Volume (2000-2012)
      • 5.2.2 Tissue Sealants Overall Volume (2000-2012)
      • 5.2.3 Hemostats Overall Volume (2000-2012)
    • 5.3 Wound Closure Devices Average Price (2000-2012)
      • 5.3.1 Hemostats Average Price (2000-2012)
      • 5.3.2 Tissue Sealants Average Price (2000-2012)
      • 5.3.3 Skin Closure Devices Average Price (2000-2012)
    • 5.4 Wound Closure Devices Distribution Share (2005-2006)
    • 5.5 Wound Closure Devices Company Share (2005-2006)
  • 6 Ostomy in Belgium
    • 6.1 Ostomy Overall Revenue (2000-2012)
    • 6.2 Ostomy Overall Volume (2000-2012)
    • 6.3 Ostomy Average Price (2000-2012)
    • 6.4 Ostomy Distribution Share (2005-2006)
    • 6.5 Ostomy Company Share (2005-2006)
  • 7 Advanced Wound Management in Belgium
    • 7.1 Advanced Wound Management Overall Revenue (2000-2012)
    • 7.2 Advanced Wound Management Overall Volume (2000-2012)
    • 7.3 Advanced Wound Management Average Price (2000-2012)
    • 7.4 Advanced Wound Management Distribution Share (2005-2006)
    • 7.5 Advanced Wound Management Company Share (2005-2006)
  • 8 Traditional Wound Management
    • 8.1 Traditional Wound Management Overall Revenue (2000-2012)
    • 8.2 Traditional Wound Management Overall Volume (2000-2012)
    • 8.3 Traditional Wound Management Average Price (2000-2012)
    • 8.4 Traditional Wound Management Distribution Share (2005-2006)
    • 8.5 Traditional Wound Management Company Share (2005-2006)
  • 9 Compression Therapy in Belgium
    • 9.1 Compression Therapy Overall Revenue (2000-2012)
    • 9.2 Compression Therapy Overall Volume (2000-2012)
    • 9.3 Compression Therapy Average Price (2000-2012)
    • 9.4 Compression Therapy Distribution Share (2005-2006)
    • 9.5 Compression Therapy Company Share (2005-2006)
  • 10 Baxter International Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
      • 10.2.1 BioScience
      • 10.2.2 Medication Delivery
      • 10.2.3 Renal
      • 10.2.4 Products
      • 10.2.5 History
    • 10.3 Value Chain Analysis
      • 10.3.1 Manufacturing
      • 10.3.2 Product Development
      • 10.3.3 Sales and Marketing
    • 10.4 SWOT Analysis
      • 10.4.1 Baxter International Inc. Strengths
      • 10.4.2 Baxter International Inc. Weaknesses
      • 10.4.3 Baxter International Inc. Opportunities
      • 10.4.4 Baxter International Inc. Threats
    • 10.5 Financial and Operational Review
    • 10.6 Locations And Subsidiaries
    • 10.7 Financial Deals Landscape
      • 10.7.1 Baiyunshan And Baxter Form A Joint Venture In China
      • 10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration
      • 10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital
      • 10.7.4 B. Braun Acquires Renal Therapy Business Of Baxter
      • 10.7.5 Innovata signs a license agreement with Baxter International
      • 10.7.6 Kuros Biosurgery Signs An Agreement With Baxter International
      • 10.7.7 Gambro Signs An Agreement With Baxter
      • 10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement
      • 10.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System
      • 10.7.10 Baxter International And Kaketsuken Enter Into Agreement
      • 10.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful
    • 10.8 Recent Developments
      • 10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007
      • 10.8.2 Dec 18, 2007: Baxter Elects CFO
      • 10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend
      • 10.8.4 Aug 01, 2007: Baxter Elects New Board Director
      • 10.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend
      • 10.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization
      • 10.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend
      • 10.8.8 Nov 28, 2006: Baxter Announces Annual Dividend
      • 10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America
    • 10.9 Baxter International Inc. Pipeline Products
      • 10.9.1 Next-Generation Home Hemodialysis Machine
  • 11 The HARTMANN GROUP Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
      • 11.2.1 Incontinence Management
      • 11.2.2 Operating Theater Management
      • 11.2.3 Other GROUP Activities
      • 11.2.4 Wound Management
      • 11.2.5 Products
      • 11.2.6 History
    • 11.3 Value Chain Analysis
      • 11.3.1 Manufacturing
      • 11.3.2 Product Development
      • 11.3.3 Sales and Marketing
    • 11.4 SWOT Analysis
      • 11.4.1 HARTMANN GROUP Strengths
      • 11.4.2 HARTMANN GROUP Weaknesses
      • 11.4.3 HARTMANN GROUP Opportunities
      • 11.4.4 HARTMANN GROUP Threats
    • 11.5 Financial and Operational Review
    • 11.6 Locations And Subsidiaries
    • 11.7 Recent Developments
      • 11.7.1 Mar 17, 2008: Hartmann Declares 2007 Results
      • 11.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia
      • 11.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm
      • 11.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results
  • 12 Coloplast A/S Company Profile
    • 12.1 Company Overview
    • 12.2 Business Overview
      • 12.2.1 Medical Care
      • 12.2.2 Major Products and Services
      • 12.2.3 History
    • 12.3 Value Chain Analysis
      • 12.3.1 Manufacturing
      • 12.3.2 Product Development
      • 12.3.3 Sales and Marketing
    • 12.4 SWOT Analysis
      • 12.4.1 Coloplast A/S Strengths
      • 12.4.2 Coloplast A/S Weaknesses
      • 12.4.3 Coloplast A/S Opportunities
      • 12.4.4 Coloplast A/S Threats
    • 12.5 Financial and Operational Review
      • 12.5.1 Financial Statements
      • 12.5.2 Financial Ratios
      • 12.5.3 Share Holding Structure
    • 12.6 Locations And Subsidiaries
    • 12.7 Financial Deals Landscape
      • 12.7.1 Coloplast Sells Brachytherapy Business To Core Oncology
      • 12.7.2 Coloplast Signs Distribution Agreement With Carbon Medical Technologies
      • 12.7.3 Granville Baird Capital Partners Advisors Acquires Coloplast's Business Unit
      • 12.7.4 McKesson Corporation Acquires Sterling Medical Services
      • 12.7.5 Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor
    • 12.8 Recent Developments
      • 12.8.1 Apr 07, 2008: Coloplast Plans To Invest EUR100 Million In Hungary
      • 12.8.2 Feb 19, 2008: Coloplast Declares Q1 Fiscal 2008 Results
      • 12.8.3 Nov 20, 2007: Coloplast Declares Fiscal 2007 Results
      • 12.8.4 Aug 16, 2007: Coloplast Declares Nine Months Ended 2007 Results
      • 12.8.5 May 15, 2007: Colplast Declares H1 2007 Results
      • 12.8.6 Feb 08, 2007: Coloplast Declares Q1 Fiscal 2007 Results
      • 12.8.7 Dec 13, 2006: Coloplast Appoints New Chairman
      • 12.8.8 Nov 15, 2006: Coloplast Declares Fiscal 2006 Results
  • 13 ConvaTec Company Profile
    • 13.1 Company Overview
    • 13.2 Business Overview
      • 13.2.1 Major Products and Services
      • 13.2.2 History
    • 13.3 Locations And Subsidiaries
    • 13.4 Recent Developments
      • 13.4.1 Jan 22, 2008: Vivolution Acquires Patent From BMS
      • 13.4.2 Nov 12, 2007: Alltracel Signs Development Agreement With ConvaTec
  • 14 Ethicon, Inc. Company Profile
    • 14.1 Company Overview
    • 14.2 Business Overview
      • 14.2.1 Products
    • 14.3 Locations And Subsidiaries
    • 14.4 Financial Deals Landscape
      • 14.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON
      • 14.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON
      • 14.4.3 ETHICON Acquires Vascular Control Systems
      • 14.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON
  • 15 Regulation System
    • 15.1 Medical Equipment Approval Process
      • 15.1.1 Classification
      • 15.1.2 Conformity Assessment Process
    • 15.2 Notification Fee
  • 16 Pricing and Reimbursement
    • 16.1 Reimbursement Policies
  • 17 Distribution Structure
  • 18 APPENDIX
    • 18.1 Global Markets Direct Research Methodology
    • 18.2 Coverage
    • 18.3 Secondary Research
    • 18.4 Primary Research
    • 18.5 Models
    • 18.6 Forecasts
    • 18.7 Expert Panels
    • 18.8 Currency Conversion
    • 18.9 Contact Us
    • 18.10 Disclaimer
    • 1.1 List Of Tables
    • Table 1: Hospitals and Hospital Beds in Belgium, 2005
    • Table 2: Number of Doctors by Specialty in Belgium, 2003-2007
    • Table 3: Number of Hospital Wards by Specialty in Belgium, 2003-2007
    • Table 4: Wound Care Management, Belgium, Overall Revenues ($ mn), 2000-2012
    • Table 5: Wound Care Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 6: Wound Care Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 7: Wound Care Management, Belgium, Category Revenues ($ mn), 2000-2012
    • Table 8: Wound Care Management, Belgium, Category Revenues ($ mn), Historic, 2000-2007
    • Table 9: Wound Care Management, Belgium, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 10: Wound Care Management, Belgium, Category Volume (Units), 2000-2012
    • Table 11: Wound Care Management, Belgium, Category Volume (Units), Historic, 2000-2007
    • Table 12: Wound Care Management, Belgium, Category Volume (Units), Forecast, 2007-2012
    • Table 13: Wound Care Management, Belgium, Company Share by Revenue ($ mn), 2005-2006
    • Table 14: Wound Closure Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 15: Wound Closure Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 16: Wound Closure Devices, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 17: Wound Closure Devices, Belgium, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 18: Skin Closure Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 19: Skin Closure Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 20: Hemostats, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 21: Hemostats, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 22: Tissue Sealants, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 23: Tissue Sealants, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 24: Wound Closure Devices, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Table 25: Wound Closure Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Table 26: Skin Closure Devices, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Table 27: Skin Closure Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Table 28: Tissue Sealants, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Table 29: Tissue Sealants, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Table 30: Hemostats, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Table 31: Hemostats, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Table 32: Hemostats, Belgium, Average Price ($), Historic, 2000-2007
    • Table 33: Hemostats, Belgium, Average Price ($), Forecast, 2007-2012
    • Table 34: Tissue Sealants, Belgium, Average Price ($), Historic, 2000-2007
    • Table 35: Tissue Sealants, Belgium, Average Price ($), Forecast, 2007-2012
    • Table 36: Skin Closure Devices, Belgium, Average Price ($), Historic, 2000-2007
    • Table 37: Skin Closure Devices, Belgium, Average Price ($), Forecast, 2007-2012
    • Table 38: Wound Closure Devices, Belgium, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 39: Wound Closure Devices, Belgium, Company Share by Revenue ($ mn), 2005-2006
    • Table 40: Ostomy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 41: Ostomy, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 42: Ostomy, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Table 43: Ostomy, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Table 44: Ostomy, Belgium, Average Price ($), Historic, 2000-2007
    • Table 45: Ostomy, Belgium, Average Price ($), Forecast, 2007-2012
    • Table 46: Ostomy, Belgium, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 47: Ostomy, Belgium, Company Share by Revenue ($ mn), 2005-2006
    • Table 48: Advanced Wound Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 49: Advanced Wound Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 50: Advanced Wound Management, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Table 51: Advanced Wound Management, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Table 52: Advanced Wound Management, Belgium, Average Price ($), Historic, 2000-2007
    • Table 53: Advanced Wound Management, Belgium, Average Price ($), Forecast, 2007-2012
    • Table 54: Advanced Wound Management, Belgium, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 55: Advanced Wound Management, Belgium, Company Share by Revenue ($ mn), 2005-2006
    • Table 56: Traditional Wound Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 57: Traditional Wound Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 58: Traditional Wound Management, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Table 59: Traditional Wound Management, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Table 60: Traditional Wound Management, Belgium, Average Price ($), Historic, 2000-2007
    • Table 61: Traditional Wound Management, Belgium, Average Price ($), Forecast, 2007-2012
    • Table 62: Traditional Wound Management, Belgium, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 63: Traditional Wound Management, Belgium, Company Share by Revenue ($ mn), 2005-2006
    • Table 64: Compression Therapy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 65: Compression Therapy, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 66: Compression Therapy, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Table 67: Compression Therapy, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Table 68: Compression Therapy, Belgium, Average Price ($), Historic, 2000-2007
    • Table 69: Compression Therapy, Belgium, Average Price ($), Forecast, 2007-2012
    • Table 70: Compression Therapy, Belgium, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 71: Compression Therapy, Belgium, Company Share by Revenue ($ mn), 2005-2006
    • Table 72: Baxter International Inc., SWOT Analysis, 2006
    • Table 73: Baxter International Inc., Financial Statements, USD Million, 2002-2006
    • Table 74: Baxter International Inc., Financial Ratios, USD Million, 2002-2006
    • Table 75: Baxter International Inc., Other Locations
    • Table 76: Baxter International Inc., Subsidiaries
    • Table 77: HARTMANN GROUP, SWOT Analysis, 2006
    • Table 78: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006
    • Table 79: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006
    • Table 80: HARTMANN GROUP, Subsidiaries
    • Table 81: Coloplast A/S, SWOT Analysis, 2007
    • Table 82: Coloplast A/S, Financial Statements, DKK Million, 2003-2007
    • Table 83: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007
    • Table 84: Coloplast A/S, Share Holding Structure
    • Table 85: Coloplast A/S, Other Locations
    • Table 86: Coloplast A/S, Subsidiaries
    • Table 87: Coloplast A/S, Subsidiaries(Contd.)
    • Table 88: ConvaTec, Other Locations
    • Table 89: Ethicon, Inc., Other Locations
    • Table 90: Ethicon, Inc., Subsidiaries
    • Table 91: Medical Equipment Notification Fee in Belgium, 2007
    • Table 92: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • List of Figures
    • Figure 1: Total Healthcare Expenditure in Belgium, 2000 - 2006
    • Figure 2: Structure of Healthcare System in Belgium, 2007
    • Figure 3: Wound Care Management, Belgium, Overall Revenues ($ mn), 2000-2012
    • Figure 4: Wound Care Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 5: Wound Care Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 6: Wound Care Management, Belgium, Category Revenues ($ mn), 2000-2012
    • Figure 7: Wound Care Management, Belgium, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 8: Wound Care Management, Belgium, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 9: Wound Care Management, Belgium, Category Volume (Units), 2000-2012
    • Figure 10: Wound Care Management, Belgium, Category Volume (Units), Historic, 2000-2007
    • Figure 11: Wound Care Management, Belgium, Category Volume (Units), Forecast, 2007-2012
    • Figure 12: Wound Care Management, Belgium, Company Share (%), 2006
    • Figure 13: Wound Closure Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 14: Wound Closure Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 15: Wound Closure Devices, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 16: Wound Closure Devices, Belgium, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 17: Skin Closure Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 18: Skin Closure Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 19: Hemostats, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 20: Hemostats, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 21: Tissue Sealants, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 22: Tissue Sealants, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 23: Wound Closure Devices, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Figure 24: Wound Closure Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Figure 25: Skin Closure Devices, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Figure 26: Skin Closure Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Figure 27: Tissue Sealants, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Figure 28: Tissue Sealants, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Figure 29: Hemostats, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Figure 30: Hemostats, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Figure 31: Hemostats, Belgium, Average Price ($), Historic, 2000-2007
    • Figure 32: Hemostats, Belgium, Average Price ($), Forecast, 2007-2012
    • Figure 33: Tissue Sealants, Belgium, Average Price ($), Historic, 2000-2007
    • Figure 34: Tissue Sealants, Belgium, Average Price ($), Forecast, 2007-2012
    • Figure 35: Skin Closure Devices, Belgium, Average Price ($), Historic, 2000-2007
    • Figure 36: Skin Closure Devices, Belgium, Average Price ($), Forecast, 2007-2012
    • Figure 37: Wound Closure Devices, Belgium, Distribution Share (%), 2006
    • Figure 38: Wound Closure Devices, Belgium, Company Share (%), 2006
    • Figure 39: Ostomy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 40: Ostomy, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 41: Ostomy, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Figure 42: Ostomy, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Figure 43: Ostomy, Belgium, Average Price ($), Historic, 2000-2007
    • Figure 44: Ostomy, Belgium, Average Price ($), Forecast, 2007-2012
    • Figure 45: Ostomy, Belgium, Company Share (%), 2006
    • Figure 46: Advanced Wound Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 47: Advanced Wound Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 48: Advanced Wound Management, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Figure 49: Advanced Wound Management, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Figure 50: Advanced Wound Management, Belgium, Average Price ($), Historic, 2000-2007
    • Figure 51: Advanced Wound Management, Belgium, Average Price ($), Forecast, 2007-2012
    • Figure 52: Advanced Wound Management, Belgium, Distribution Share (%), 2006
    • Figure 53: Advanced Wound Management, Belgium, Company Share (%), 2006
    • Figure 54: Traditional Wound Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 55: Traditional Wound Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 56: Traditional Wound Management, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Figure 57: Traditional Wound Management, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Figure 58: Traditional Wound Management, Belgium, Average Price ($), Historic, 2000-2007
    • Figure 59: Traditional Wound Management, Belgium, Average Price ($), Forecast, 2007-2012
    • Figure 60: Traditional Wound Management, Belgium, Distribution Share (%), 2006
    • Figure 61: Traditional Wound Management, Belgium, Company Share (%), 2006
    • Figure 62: Compression Therapy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 63: Compression Therapy, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 64: Compression Therapy, Belgium, Overall Volume (Units), Historic, 2000-2007
    • Figure 65: Compression Therapy, Belgium, Overall Volume (Units), Forecast, 2007-2012
    • Figure 66: Compression Therapy, Belgium, Average Price ($), Historic, 2000-2007
    • Figure 67: Compression Therapy, Belgium, Average Price ($), Forecast, 2007-2012
    • Figure 68: Compression Therapy, Belgium, Distribution Share (%), 2006
    • Figure 69: Compression Therapy, Belgium, Company Share (%), 2006
    • Figure 70: Baxter International Inc., Value Chain Analysis
    • Figure 71: HARTMANN GROUP, Value Chain Analysis
    • Figure 72: Coloplast A/S, Value Chain Analysis
    • Figure 73: Flowchart for Classification of Non-invasive Devices in Belgium, 2007
    • Figure 74: Flowchart for Classification of Invasive Devices in Belgium, 2007
    • Figure 75: Flowchart for Classification of Invasive Devices in Belgium, 2007
    • Figure 76: Flowchart for Classification of Invasive Devices in Belgium, 2007
    • Figure 77: Flowchart for Classification of Invasive Devices in Belgium, 2007
    • Figure 78: Flowchart for Classification of Active Devices in Belgium, 2007
    • Figure 79: Flowchart for Classification of Active Devices in Belgium, 2007
    • Figure 80: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Belgium, 2007
    • Figure 81: Conformity Assessment of Class-I Medical Devices in Belgium, 2007
    • Figure 82: Conformity Assessment of Class-IIa Medical Devices in Belgium, 2007
    • Figure 83: Conformity Assessment of Class-IIb Medical Devices in Belgium, 2007
    • Figure 84: Conformity Assessment of Class-III Medical Devices in Belgium, 2007
    • Figure 85: Global Markets Direct Methodology